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Background: Catheter-related bloodstream infection (CRBSI) surveillance serves as a quality improvement measure
that is often used to assess performance. We reviewed the total number of microbiological samples collected in
three Belgian intensive care units (ICU) in 2009–2010, and we described variations in CRBSI rates based on
two factors: microbiological documentation rate and CRBSI definition which includes clinical criterion for
coagulase-negative Staphylococcus (CNS) episode.
Findings: CRBSI rates were 2.95, 1.13 and 1.26 per 1,000 estimated catheter-days in ICUs A, B and C, respectively.
ICU B cultured fewer microbiological samples and reported the lowest CRBSI rate. ICU C had the highest
documentation rate but was assisted by support available from the laboratory for processing single CNS positive
blood cultures. With the exclusion of clinical criterion, CRBSI rates would be reduced by 19%, 45% and 0% in ICUs
A, B and C, respectively.
Conclusion: CRBSI rates may be biased by differences of blood culture sampling and CRBSI definition. These
observations suggest that comparisons of CRBSI rates in different ICUs remain difficult to interpret without
knowledge of local practices.
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Nosocomial bloodstream infections (BSIs) are an important
problem worldwide. BSIs comprised 14% of all nosocomial
infections in Belgium in 2007 [1]. Catheter-related
bloodstream infection (CRBSI) is a leading cause of
BSI, particularly in intensive care units (ICUs), where
it is associated with significant patient morbidity and
mortality and increased health care costs [2]. In 2010,
the Belgian National Program for Surveillance of Hospital
Infections (NSHI) reported a mean incidence of CRBSI
of 1.4 (95% CI: 1.3-1.5) per 10,000 patient-days [3].
The comparison of CRBSI rates between hospitals as a
quality indicator and for identification and implemen-
tation of prevention strategies remains complex and
controversial [4,5]. We hypothesized that even using
the same definition, comparing rates of CRBSI between
different ICUs may be inappropriate. Other variables,* Correspondence: soraya.cherifi@chu-brugmann.be
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reproduction in any medium, provided the orsuch as the total number of blood cultures obtained and
the clinical and laboratory protocols used for the manage-
ment of blood cultures positive for skin contaminants could
have an influence on the rates of CRBSI. This study ana-
lyses retrospective data on CRBSI rates from three different
ICUs and discusses the limitations of CRBSI surveillance.
Methods
This retrospective study was conducted in three hospitals
in Brussels, Belgium. Hospitals A and B are tertiary teach-
ing hospitals that are affiliated with the same university, i.e.,
the Université Libre de Bruxelles. Hospitals A and B have
854 and 509 beds, respectively. Hospital C is an academic
hospital, and it has 864 beds. Each hospital has an ICU with
both medical and surgical critical care beds: 30 beds in
ICU-A, 20 beds in ICU-B, and 31 beds in ICU-C. The
study population consisted of all patients admitted to the
ICUs who developed a CRBSI between January 2009 and
December 2010. Cases were retrospectively identified
through a search in the microbiological database of each
hospital. Only medical records of patients with CRBSI withLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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skin contaminant were examined further for antimicrobial
treatment. We did not collect information regarding sever-
ity of illness. In 2011, a six-month prospective surveillance
study was conducted in ICUs A and B to measure the CVC
utilization ratio (defined as the ratio between catheter-days
and patient-days), resulting in a ratio of 0.75. The mean
CVC utilization ratio in ICU-C was estimated to be 0.89
(min 0.70, max 1), with 31 point prevalence surveys
performed by a local infection control team in 2012.
According to the national surveillance protocol for BSI
in Belgium [3], we defined CRBSI as a BSI with: 1) at
least one positive blood culture for a recognized pathogen
and a positive quantitative CVC tip culture for the same
organism or 2a) at least 2 positive blood cultures for a
skin contaminant (e.g., coagulase-negative Staphylococcus
(CNS)) and a positive CVC tip culture or 2b) one single
peripheral positive blood culture positive for CNS and a
positive CVC tip culture with appropriately instituted anti-
microbial therapy. Catheter tips were processed using
Maki’s semi-quantitative culture method [6].
The following microbiological data were recorded:
number of cultured catheter tips, number of colonized
catheter tips, number of blood cultures, number of positive
blood cultures, and number of catheter tips removed with
concomitant blood cultures. Each hospital had infection
control programs and participated in the National Hand
Hygiene Campaign in the winter of 2010–2011 [7]. Local
procedures for CVC insertion followed standard guidelines,
including the use of full sterile barrier precautions during
insertion, a 0.5% chlorhexidine alcoholic antiseptic for
skin preparation, and hand hygiene. No catheters coated
with antimicrobial agents or impregnated with antiseptic
were used.
In the laboratories of hospitals A and B, complete strain
identification and susceptibility tests were performed on
all blood cultures (recognized pathogens and CNS) and
catheter tip cultures. In hospital C, species identification
of CVC tip cultures was only performed in cases in which
one peripheral blood culture (out of two or three) was
positive for CNS. If the species were concordant and if the
attending physician requested it, an antimicrobial suscep-
tibility profile was then performed, which could take up to
48 hours. Protocols for drawing blood cultures were the
same in each of the 3 ICUs: “collection of 2 blood cultures
per episode whenever possible using venepuncture and
not through an intravascular device”.
Chi-squared tests were used to compare categorical
variables. Statistical significance was designated as a 2-sided
p-value of < 0.05.
Results
During the 2-year period, using criteria 1, 2a and 2b, 71
episodes of CRBSI occurred during 47,991 patient-daysand 38,248 estimated catheter-days: 42 in ICU-A, 11 in
ICU-B, and 18 in ICU-C. The numbers of catheters and
blood samples cultured per ICU are reported in detail in
Table 1.
The isolated microorganisms are described in Table 2. The
microorganism most frequently isolated was Staphylococcus
epidermidis (n = 17). The ratio of CRBSI-documented
infections (number of blood cultures with concomitant
catheter tip cultures) was also statistically different
between the 3 ICUs (P < 0.001). This result remained
significant if the number of blood cultures was used
instead of patient-days.
The CRBSI rates were 2.95, 1.13 and 1.26 per 1,000
estimated catheter-days in ICUs A, B and C, respectively.
There were a total of 8 single CNS positive blood cul-
tures in ICU-A (all treated with antibiotics), 7 in ICU-B
(5 treated), and 12 in ICU-C (none treated). CRBSI rates
based on the exclusion of criterion 2b were 2.39, 0.62
and 1.26 per 1,000 estimated catheter-days in ICUs A, B
and C, respectively. The ratios of CRBSIs was statistically
different between the 3 ICUs (P = 0.003), even when
criterion 2b was removed (P = 0.003).
With the exclusion of criterion 2b (if all CNS BSIs
were processed according to laboratory routine C and/or
managed with a strict reduction in initiation of antibiotic
treatment), the ranking of CRBSIs would not be modified;
however, a reduction of CRBSI rates of 19% and 45% in
ICU-A and -B, respectively, would be seen.
Discussion
Benchmarking of surveillance data for health-care-
associated infections, especially for central line-associated
bloodstream infections (CLABSI), has been used for more
than two decades to identify prevention strategies and to
improve patient safety.
The criteria used to define intravascular catheter-related
infection are difficult to apply; perhaps more simplified
methods of surveillance that rely entirely on objective
criteria would be a better option [8]. CLABSI refers to a
primary BSI in a patient who had a central venous line
within the 48-hour period prior to development of the BSI
that was not related to an infection at another site [9]. A
secondary BSI from an undocumented source could be
erroneously labelled a CLABSI, overestimating the true
incidence [10]. In Belgium, the national surveillance
protocol for healthcare-associated BSIs makes a dis-
tinction between “proven” or “probable” CLABSI [3].
These confusing definitions increase the ambiguity in
classification and justify the use of the CRBSI definition
instead of the CLABSI definition in this retrospective
study. In reality, measurement of catheter-days is rela-
tively time consuming and not routinely performed. In
addition, infection control departments have different
interpretations of criteria for calculating catheter-days,
Table 1 Number of catheters and blood samples cultured per intensive care unit
Intensive care unit (ICU) ICU-A ICU-B ICU-C Total
Ratio of positive catheter tips (%) 123/543 (23%) 48/398 (12%) 89/1,321 (7%) 260/2,262 (11%)
Catheters tips cultured per 1,000 patient-days 29 31 82 47
Ratio of positive blood cultures (%) 1,041/5,578 (19%) 746/4,147 (18%) 845/6,534 (13%) 2,632/16,259 (16%)
Blood culture rate per 1,000 patient-days 291 321 406 339
Number of catheter tips cultured with concomitant blood cultures 489 254 1,094 1,837
Catheter tips cultured with concomitant blood cultures
per 1,000 patient-days
26 20 68 38
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reasonable to assume that estimation of catheter-days will
result in a smaller impact on the rates of CRBSI [12-14].
We examined two factors that are known to impact
measured CRBSI rates: microbiological documentation
rate and definition including clinical criterion influenced
by individual local practices.
Inappropriate CVC tip and blood cultures generate a
large workload and are a poor use of laboratory resources.
In the 3 ICUs, many tips were cultured without con-
comitant blood cultures. Numerous studies have shown
that 15 to 25% of short-term CVC cultures are colo-
nized, most commonly by CNS, though most patients
show no evidence of infection [15,16]. Differences in
microbiological documentation make comparisons be-
tween ICUs difficult to interpret. The total number of
blood cultures sampled in ICU-C was higher than in
ICUs A and B, higher than the national average of 42
per 1,000 patient-days (including non-ICU patients) [3]
and higher than the median of 73 per 1,000 patient days
reported in European countries [17]. The considerable
number of microbiological analyses done in ICU-C
might be justified, as the patients in ICU-C, who included
transplant patients, haematological patients at high risk of
complications, and patients who were transferred from
others hospitals, are more likely to have severe health
problems. In contrast, the total number of blood cultures
performed in ICU-B with concomitant catheter-tip culturesTable 2 Distribution of microorganisms isolated from
CRBSIs
Microorganisms ICU-A ICU-B ICU-C Total
Gram-positive cocci 23 10 8 41
Coagulase-negative Staphylocci 13 9 2 24
Staphylococcus aureus 9 0 4 13
Enteroccocus sp. 1 1 2 4
Gram-negative bacilli 15 1 9 25
Enterobacteriaceae 12 1 5 17
Other Gram-negative Bacilli 3 0 4 7
Yeasts 4 0 1 5
Total 42 11 18 71was lower than in ICUs A and C. ICU-B also had the
lowest CRBSI rate. The number of blood cultures
performed could have a significant influence on CRBSI
rates, as demonstrated by Gastmeier et al. [18]. Niedner
et al. found a significant correlation between a surveillance
aggressiveness score and higher CRBSI rates [11]. We did
not collect clinical information that could explain the high
CRBSI rate in ICU-A. However, both ICUs A and B
managed patients that were usually less complicated
than those treated in the academic hospital.
Today, CNS is recognized as the most common cause of
CRBSI, consistent with the results from our study. Local la-
boratory practices (incomplete identification of single CNS
blood culture) could influence how the physician decides
whether a single peripheral CNS-positive blood culture is a
contaminant. It could explain how zero CRBSI episodes
fulfilled criterion 2b in ICU-C. The clinical importance of a
single CNS positive blood culture also depends on phys-
ician training and experience. Moreover, an uncomplicated
CRBSI caused by CNS may not necessarily require a treat-
ment [19]. The use of clinical criterion (criterion 2b) intro-
duces a bias that makes comparisons very difficult. In ICUs
A and B, treatment of patients with a possibly contami-
nated blood culture combined with catheter colonization
could have accounted for a certain number of CNS CRBSI.
However, in our national protocol of BSI surveillance, CNS
BSI represented a minority (14%) of the total reported BSIs,
and among this group, CNS BSI with at least 2 positive
blood cultures constituted the majority (79%) (3). The CDC
CLABSI definition changed beginning in 2008, correctly
removing criterion 2b [20].
Our study has several limitations. First, the results are
limited by the study’s retrospective nature and by the
small sample size. Second, we did not collect any clinical
data except for the administration of antibiotic treatment.
Finally, the number of catheter-days was estimated with
two different methods and at different periods. Therefore,
comparison of CRBSI rates between ICUs might have
been distorted.
Conclusion
Our study describes the variation in measured CRBSI rates
in 3 neighbouring hospitals based on laboratory processes
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hospital performance is dependent on many variables
that are beyond the epidemiologist’s control.
Better prospective studies are needed to improve the
quality and reproducibility of surveillance definitions and
to identify the best practice for a benchmark approach.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SC and BB were responsible for the study concept and design. SC, GM, AD,
and MH performed data collection. SC, BB, MG, and MH were responsible for
data analysis. All authors were involved in drafting the manuscript or revising
critically for important intellectual content. All authors have read and
approved the manuscript.
Acknowledgements
Special thanks to nurse Sylvie Arias for assistance in data collection.
Funding
This project was funded by the IRIS Research Fund (Fonds Iris Recherche)
n°: 2011-R20690-001 managed by the King Baudouin Foundation
(Fondation Roi Baudouin).
Author details
1Infection Control Unit, Brugmann University Hospital, Place A. Van
Gehuchten, 4, Brussels 1020, Belgium. 2Microbiology Department, Brugmann
Hospital, Brussels, Belgium. 3Microbiology Department, Saint Pierre Hospital,
Brussels, Belgium. 4Microbiology Department, Erasme University Hospital,
Brussels, Belgium. 5Infection Control Unit, Saint Pierre Hospital, Brussels,
Belgium. 6Healthcare-associated infections unit, Public Health and
Surveillance department, Scientific Institute of Public Health, Brussels,
Belgium. 7Infection Control Unit, Erasme University Hospital, Brussels,
Belgium. 8School of Public Health, Université Libre de Bruxelles, Brussels,
Belgium. 9Present address: Centre de Diagnostic Moléculaire, Iris-Lab,
Brussels, Belgium.
Received: 28 January 2013 Accepted: 29 March 2013
Published: 3 April 2013
References
1. Vrijens F, Gordts B, De Laet C, Devriese S, Van De Sande S, Huybrechts M,
Peeters G, Hulstaert: Les infections nosocomiales en Belgique: Volet I, Etude
Nationale de Prévalence, Health Services Research (HSR). Bruxelles: Centre
fédéral d’expertise des soins de santé (KCE), KCE reports 92B; 2008.
doi:D/2008/10.273/71.
2. National Nosocomial Infections Surveillance System: National Nosocomial
infections surveillance (NNIS) system report, data summary from January
1992 through June 2004. Am J Infect Control 2004, 32:470–485.
3. National Surveillance of Hospital Infections. Scientific Institute of Public
Health, Belgique: National surveillance of nosocomial septicemia (hospital-wide).
2010. http://www.nsih.be/download/SEP/sBelg_2010_data.pdf.
4. Haustein T, Gastmeier P, Holmes A, Lucet JC, Shannon RP, Pittet D, Harbarth
S: Use of benchmarking and public reporting for infection control in four
high-income countries. Lancet Infect Dis 2011, 11:471–481.
5. Limb M: Variations in collecting data on central line infections make
comparison of hospitals impossible, say researchers. BMJ 2012,
21(345):345. e6377.
6. Maki DG, Weise CE, Sarafin HW: A semi-quantitative culture method for
identifying intravenous catheter-related infection. N Engl J Med 1977,
296:1305–1309.
7. Costers M, Viseur N, Catry B, Simon A: Four multifaceted countrywide
campaigns to promote hand hygiene in Belgian hospitals between 2005
and 2011: impact on compliance to hand hygiene. Euro Surveill 2012,
3(18):pii=20161.
8. Rubin MA, Mayer J, Greene T, Sauer BC, Hota B, Trick W, Jernigan JA,
Samore MH: An agent-based model for evaluating surveillance methods
for catheter-related bloodstream infection. AMIA Annu Symp Proc 2008,
6:631–635.9. Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of
health care-associated infection and criteria for specific types of
infections in the acute care setting. Am J Infect Control 2008, 36:309–332.
10. Sihler KC, Chenoweth C, Zalewski C, Wahl W, Hyzy R, Nopolitano LM:
Catheter-related vs catheter-associated blood stream infections in the
intensive care unit: incidence, microbiology, and implications. Surg Infect
2010, 11:529–534.
11. Niedner MF: and NACHRI: The harder you look, the more you find:
catheter-associated bloodstream infection surveillance variability.
Am J Infect Control 2010, 38:585–595.
12. Woeltje KF, Butler AM, Goris AJ, Tutlam NT, Doherty JA, Westover MB,
Ferris V, Bailey TC: Automated surveillance for central line-associated
bloodstream infection in intensive care units. Infect Control Hosp
Epidemiol 2008, 29:842–846.
13. Worth LJ, Brett J, Bull AL, McBryde ES, Russo PL, Richards MJ: Impact of
revising the National Nosocomial Infection Surveillance System
definition for catheter-related bloodstream infection in ICU:
reproducibility of National Healthcare Safety Network case definition in
an Australian cohort of infection control professionals. Am J Infect Control
2009, 37:643–648.
14. McBryde ES, Brett J, Russo PL, Worth LJ, Bull AL, Richards MJ: Validation of
statewide surveillance system data on central line-associated
bloodstream infection in intensive care units in Australia. Infect Control
Hosp Epidemiol 2009, 30:1045–1049.
15. Gowardman JR, Montgomery C, Thirlwell S, Shewan J, Idema A, Larsen PD,
Havill JH: Central venous catheter-related bloodstream infections: an
analysis of incidence and risk factors in a cohort of 400 patients. Intensive
Care Med 1998, 24:1034–1039.
16. Tacconelli E, Tumbarello M, Pittiruti M, Leone F, Lucia MB, Cauda R, Ortona
L: Central venous catheter-related sepsis in a cohort of 366 hospitalized
patients. Eur J Clin Microbiol Infect Dis 1997, 16:203–209.
17. Hansen S, Schwab F, Behnke M, Carsauw H, Heczko P, Klavs I, Lyytikäinen O,
Palomar M, Riesenfeld Orn I, Savey A, Szilagyi E, Valinteliene R, Fabry J,
Gastmeier P: National influences on catheter-associated bloodstream
infection rates: practices among national surveillance networks
participating in the European HELICS project. J Hosp Infect 2009, 71:66–73.
18. Gastmeier P, Schwab F, Behnke M, Geffers C: Less blood culture samples:
less infections? Anaesthesist 2011, 60:902–907.
19. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II,
Rijnders BJ, Sherertz RJ, Warren DK: Clinical practice guidelines for the
diagnosis and management of intravascular catheter-related infection:
2009 Update by the Infectious Diseases Society of America. Clin Infect Dis
2009, 49:1–45.
20. National Healthcare Safety Network, Centers for Disease Control and
Prevention: The National Healthcare Safety Network (NHSN) manual patient
safety component protocol. 2008. http://www.cdc.gov/nhsn. Accessed
October 19, 2009.
doi:10.1186/2047-2994-2-10
Cite this article as: Cherifi et al.: Variations in catheter-related
bloodstream infections rates based on local practices. Antimicrobial
Resistance and Infection Control 2013 2:10.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
